Khwaja, Omar S <br/><br/>
Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Mar 2014 
 - 4596-601 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1091-6490 
<br/><br/><label>Standard No.: </label>10.1073/pnas.1311141111  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Child<br/>Child, Preschool<br/>Female<br/>Humans<br/>Insulin-Like Growth Factor I--adverse effects<br/>Intercellular Signaling Peptides and Proteins--adverse effects<br/>Recombinant Proteins--adverse effects<br/>Rett Syndrome--drug therapy